Oppenheimer Asset Management Inc. Thermo Fisher Scientific Inc. Transaction History

Oppenheimer Asset Management Inc.

  • $8.04 Billion
  • Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 90,343 shares of TMO stock, worth $46.6 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
90,343
Previous 82,916 8.96%
Holding current value
$46.6 Million
Previous $45.9 Million 21.87%
% of portfolio
0.7%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$531.86 - $624.21 $3.95 Million - $4.64 Million
7,427 Added 8.96%
90,343 $55.9 Million
Q2 2024

Aug 08, 2024
BUY
$541.52 - $599.02 $9.7 Million - $10.7 Million
17,913 Added 27.56%
82,916 $45.9 Million
Q1 2024

May 06, 2024
BUY
$528.82 - $599.43 $2.13 Million - $2.41 Million
4,020 Added 6.59%
65,003 $37.8 Million
Q4 2023

Feb 13, 2024
SELL
$431.41 - $532.94 $779,989 - $963,555
-1,808 Reduced 2.88%
60,983 $32.4 Million
Q3 2023

Nov 07, 2023
BUY
$498.29 - $574.41 $1.43 Million - $1.65 Million
2,876 Added 4.8%
62,791 $31.8 Million
Q2 2023

Aug 02, 2023
SELL
$508.46 - $591.13 $32,032 - $37,241
-63 Reduced 0.11%
59,915 $31.3 Million
Q1 2023

May 10, 2023
BUY
$535.0 - $604.82 $2.54 Million - $2.87 Million
4,740 Added 8.58%
59,978 $34.6 Million
Q4 2022

Feb 06, 2023
BUY
$484.71 - $571.37 $13.3 Million - $15.6 Million
27,346 Added 98.04%
55,238 $30.4 Million
Q3 2022

Nov 14, 2022
BUY
$507.19 - $604.49 $1.35 Million - $1.6 Million
2,653 Added 10.51%
27,892 $14.1 Million
Q2 2022

Aug 08, 2022
SELL
$500.9 - $612.21 $49,589 - $60,608
-99 Reduced 0.39%
25,239 $13.7 Million
Q1 2022

May 12, 2022
SELL
$524.0 - $644.92 $4.61 Million - $5.68 Million
-8,805 Reduced 25.79%
25,338 $15 Million
Q4 2021

Feb 02, 2022
SELL
$569.0 - $667.24 $42,675 - $50,043
-75 Reduced 0.22%
34,143 $22.8 Million
Q3 2021

Nov 12, 2021
BUY
$509.53 - $609.78 $295,017 - $353,062
579 Added 1.72%
34,218 $19.6 Million
Q2 2021

Aug 03, 2021
BUY
$441.0 - $508.24 $107,604 - $124,010
244 Added 0.73%
33,639 $17 Million
Q1 2021

May 17, 2021
SELL
$439.85 - $518.83 $341,323 - $402,612
-776 Reduced 2.27%
33,395 $15.2 Million
Q4 2020

Feb 11, 2021
SELL
$435.06 - $527.66 $940,599 - $1.14 Million
-2,162 Reduced 5.95%
34,171 $15.9 Million
Q3 2020

Nov 13, 2020
BUY
$359.77 - $441.52 $618,084 - $758,531
1,718 Added 4.96%
36,333 $16 Million
Q2 2020

Aug 11, 2020
BUY
$275.2 - $362.34 $497,011 - $654,386
1,806 Added 5.5%
34,615 $12.5 Million
Q1 2020

May 08, 2020
SELL
$255.3 - $340.05 $214,707 - $285,982
-841 Reduced 2.5%
32,809 $9.31 Million
Q4 2019

Feb 07, 2020
BUY
$271.93 - $328.04 $109,315 - $131,872
402 Added 1.21%
33,650 $10.9 Million
Q3 2019

Oct 31, 2019
SELL
$268.46 - $305.43 $218,794 - $248,925
-815 Reduced 2.39%
33,248 $9.68 Million
Q2 2019

Aug 09, 2019
SELL
$257.51 - $295.55 $438,797 - $503,617
-1,704 Reduced 4.76%
34,063 $10 Million
Q1 2019

Apr 24, 2019
SELL
$212.17 - $273.72 $1.55 Million - $1.99 Million
-7,286 Reduced 16.92%
35,767 $9.79 Million
Q4 2018

Jan 30, 2019
SELL
$208.47 - $251.98 $517,631 - $625,666
-2,483 Reduced 5.45%
43,053 $9.63 Million
Q3 2018

Oct 26, 2018
SELL
$205.57 - $244.32 $151,916 - $180,552
-739 Reduced 1.6%
45,536 $11.1 Million
Q2 2018

Aug 10, 2018
BUY
$203.14 - $219.53 $517,803 - $559,581
2,549 Added 5.83%
46,275 $9.59 Million
Q1 2018

May 09, 2018
SELL
$192.98 - $224.11 $518,730 - $602,407
-2,688 Reduced 5.79%
43,726 $9.03 Million
Q3 2017

Nov 14, 2017
BUY
$171.74 - $194.04 $7.97 Million - $9.01 Million
46,414
46,414 $8.78 Million

Others Institutions Holding TMO

# of Institutions
2,829
Shares Held
334M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $202B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email